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Primary nociceptors relay painful touch information
from the periphery to the spinal cord. Although it is
established that signals generated by receptor tyro-
sine kinases TrkA and Ret coordinate the develop-
ment of distinct nociceptive circuits, mechanisms
modulating TrkA or Ret pathways in developing
nociceptors are unknown. We have identified tumor
necrosis factor (TNF) receptor 1 (TNFR1) as a critical
modifier of TrkA and Ret signaling in peptidergic and
nonpeptidergic nociceptors. Specifically, TrkA+
peptidergic nociceptors require TNF-a-TNFR1 for-
ward signaling to suppress nerve growth factor
(NGF)-mediated neurite growth, survival, excitability,
and differentiation. Conversely, TNFR1-TNF-a re-
verse signaling augments the neurite growth and
excitability of Ret+ nonpeptidergic nociceptors. The
developmental and functional nociceptive defects
associated with loss of TNFR1 signaling manifest
behaviorally as lower pain thresholds caused by
increased sensitivity to NGF. Thus, TNFR1 exerts a
dual role in nociceptor information processing by
suppressing TrkA and enhancing Ret signaling
in peptidergic and nonpeptidergic nociceptors,
respectively.
INTRODUCTION
The ability to discriminate between innocuous and painful touch
is critical for survival. Nociceptors are polymodal sensory
neurons that relay information about noxious tactile cues from
peripheral targets to the spinal cord (Julius and Basbaum,
2001; Craig, 2003; Basbaum et al., 2009). Importantly, nocicep-
tors are defined by their high excitability thresholds for thermal,
mechanical, or chemical stimuli, meaning that pain is perceived
only when these stimuli are potent enough to trigger action po-tentials (Woolf and Salter, 2000; Hunt andMantyh, 2001). Critical
properties of nociceptors that govern the perceived intensity of a
painful stimulus include density of peripheral target innervation,
proper targeting of central projections, and high excitability
thresholds (Pezet and McMahon, 2006). It follows that if any of
these components were enhanced or attenuated then the
perception of pain would be altered.
Target-derived nerve growth factor (NGF) initiates signaling
pathways critical for tuning nociceptor sensitivity through the
regulation of survival, neurite growth, and excitability (Crowley
et al., 1994; Patel et al., 2000; Chuang et al., 2001). Peripheral
targets such as the skin release NGF during development,
around the time that newly born nociceptors begin to innervate
peripheral targets (Marmige`re and Ernfors, 2007; Lallemend
and Ernfors, 2012). Secreted NGF binds to a receptor tyrosine
kinase (RTK), TrkA, on developing nociceptors to transduce
intracellular signals that are required for survival and target inner-
vation (Crowley et al., 1994; Patel et al., 2000). Deletion of genes
encoding NGF or TrkA causes the death of all nociceptors during
development and, as a result, pain insensitivity (Verhoeven et al.,
2006; Indo et al., 1996). Conversely, hyperactivation of NGF-
TrkA signaling skews pain thresholds toward hypersensitivity,
causing hyperalgesia or allodynia (Lewin et al., 1993; Woolf
and Salter, 2000; Costigan et al., 2009; Mantyh et al., 2011).
Thus, NGF signaling must be tightly controlled during develop-
ment such that painful stimuli are properly interpreted.
Maturation of several functionally distinct nociceptor sub-
classes also requires NGF-TrkA signaling during embryonic
and postnatal nociceptor development (Luo et al., 2007; Gascon
et al., 2010; Marmige`re and Ernfors, 2007). The two major pop-
ulations of mature nociceptor subclasses are peptidergic and
nonpeptidergic nociceptors. Peptidergic nociceptors express
TrkA, calcitonin gene-related peptide (CGRP), and substance
P throughout development and are responsive to target-derived
NGF (Lallemend and Ernfors, 2012). Nonpeptidergic nociceptors
do not express TrkA or neuropeptides, but rather express an
RTK, Ret, that is responsive to the target-derived glial cell line-
derived neurotrophic factor (GDNF) family of ligands (Airaksinen
and Saarma, 2002; Molliver et al., 1997). Loss of GDNF family
receptor a2 (GFRa2), a Ret coreceptor that responds to theNeuron 82, 587–602, May 7, 2014 ª2014 Elsevier Inc. 587
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innervation and sensitivity to inflammatory pain (Lindfors et al.,
2006). Interestingly, acute pain is sensed by TrkA+ peptidergic
nociceptors in the absence of NRTN signaling, suggesting that
TrkA+ and Ret+ nociceptors are functionally distinct from one
another in adulthood despite being derived from the same early
TrkA+ nociceptor lineage during embryonic development (Mar-
mige`re and Ernfors, 2007; Liu and Ma, 2011). Together, these
studies suggest that NGF-TrkA signaling is critical for the
orchestration of peptidergic and nonpeptidergic nociceptive
circuits that underlie the perception of distinct forms of painful
touch.
Given the broad phenotypes and functions that NGF-TrkA
signaling regulates, it stands to reason that there should be
factors that modulate TrkA signals and, by extension, nociceptor
development and function. Clues for this hypothesis come from
studies in the sympathetic nervous system, a system that also
requires NGF-TrkA signaling for survival and target innervation
(Crowley et al., 1994; Glebova and Ginty, 2004). In sympathetic
neurons, antagonism of NGF-TrkA signals can occur via the
p75 neurotrophin receptor (p75NTR) that induces death (Depp-
mann et al., 2008), promotes axon pruning (Singh et al., 2008),
dampens excitability (Luther and Birren, 2009), and restricts
postsynaptic densities (Sharma et al., 2010). As such, elimination
of p75NTR is analogous to TrkA gain of function in sympathetic
neurons. Consequently, one would expect that the loss of
p75NTR in nociceptors would manifest as heightened pain
sensitivity. However, numerous reports argue the opposite;
loss of p75NTR results in decreased pain sensitivity and reduced
cutaneous innervation by nociceptors (Lee et al., 1992; Berg-
mann et al., 1997). Nociceptors from p75NTR/ mice are
roughly 3-fold less sensitive to NGF (Davies et al., 1993; Lee
et al., 1994), suggesting that p75NTR likely augments NGF-
TrkA signaling in nociceptors.
If not p75NTR, might a different receptor gate NGF-TrkA
signaling in nociceptors? It is possible that receptors structurally
related to p75NTR may function as negative regulators of NGF-
TrkA signals in nociceptors. Indeed, p75NTR is just one of over
25 tumor necrosis factor (TNF) receptor (TNFR) superfamily
members, many of which are implicated in the modulation of
growth factor signaling (Deppmann and Janes, 2013; Locksley
et al., 2001). To test this idea, we screened for the expression
of 23 TNFR family members in the dorsal root ganglia (DRG);
this screening revealed the selective expression of three highly
related TNFR family members: TNFR1, p75NTR, and death
receptor 6 (DR6). Herein we pursued the role of TNFR1 signaling
in nociceptor development in part because it has been shown to
negatively regulate events such as neurite growth and survival in
the sympathetic nervous system (Barker et al., 2001; Kisiswa
et al., 2013). Similar to phenotypes observed in the sympathetic
nervous system, we report that TNFR1 forward signaling can
also inhibit the development of NGF-TrkA-dependent sensory
circuits by negatively regulating neurite growth, cell number,
and excitability of TrkA+ primary nociceptors. Moreover, loss
of either TNF-a or TNFR1 forward signaling drives TrkA+ noci-
ceptors toward a premature nonpeptidergic fate. Surprisingly,
we found that TNFR1 plays a dichotomous role in the function
of peptidergic and nonpeptidergic nociceptors. Although588 Neuron 82, 587–602, May 7, 2014 ª2014 Elsevier Inc.TrkA+ peptidergic nociceptors exhibit increased responsiveness
to NGF as evidenced by enhanced growth and excitability in the
absence of TNFR1 or TNF-a, the Ret+/TrkA population of
nonpeptidergic nociceptors exhibits functional impairments in
NRTN-dependent neurite outgrowth and excitability due to
absence of TNFR1-TNF-a reverse signaling. We demonstrate
that Tnf and Tnfr1 null mice are hypersensitive to several pain
modalities, likely caused by enhanced nociceptor sensitivity to
NGF. Finally, we provide genetic and biochemical evidence
that the increased gain in nociceptive signals observed in Tnf
or Tnfr1 knockouts is linked to an increase in the NGF sensitivity
of TrkA+ nociceptors. These results suggest that TNF-a and
TNFR1 coordinate the development and function of molecularly
distinct nociceptive circuits through crosstalk with TrkA and
Ret to either block or promote pain sensitivity in peptidergic
and nonpeptidergic nociceptor populations, respectively.
RESULTS
Characterization of TNF-a and TNFR1 Expression on
Nociceptors and Their Targets
In order to identify putative factors that can antagonize NGF-
TrkA-dependent signaling in nociceptors, we examined the
expression of 23 TNFR family members in embryonic day (E)
18.5 DRG, brain, or muscle via RT-PCR (Figure S1A available
online). This analysis revealed expression of three highly related
TNFR family members in the DRG: p75NTR (TNFRSF16), Dr6
(TNFRSF21), and Tnfr1 (TNFRSF1A). We focused on TNFR1,
an understudied TNFR family member in the context of nocicep-
tor development and function. Given that TNFR1 is robustly ex-
pressed in the DRG, which contains many different cell types,
we next sought to determine whether it is expressed on noci-
ceptors. To this end, we performed immunohistochemistry to
examine the percentage of colocalization of TNFR1 with
CGRP, peripherin, or TrkA at postnatal day (P)0 (Figures 1A–
1C). CGRP and TrkA represent peptidergic nociceptors,
whereas peripherin labels small-diameter unmyelinated noci-
ceptors. In each case, TNFR1 colocalizes with nociceptive
markers >99% of the time (Figure S2A). In addition, we found
that TNFR1 appears to be broadly expressed in the DRG as
it colocalizes with parvalbumin+ proprioceptive neurons
(Figure S2C).
We performed the same analysis at P30 when most nocicep-
tors are terminally specialized into distinct functional subclasses
(Lallemend and Ernfors, 2012). In addition to CGRP, TrkA, and
peripherin, we examined nonpeptidergic neurons by staining
with the fluorescently conjugated lectin IB4. We observed similar
levels of colocalization at P30 as at P0 (i.e., at least >99% of
nociceptors are positive for TNFR1) (Figures 1D–1G; Figure S2B).
We validated the TNFR1 antibody (Figure S1B) and found that
TNFR1 is localized to both the cell bodies and axons of sensory
neurons both in vivo (Figure S1C) and in vitro (Figure S1D).
Together, these analyses suggest that TNFR1 is ubiquitously
expressed by nociceptors across different stages of sensory
circuit development, ranging from early to mature nociceptor
populations.
We also sought to localize the sources of TNF-a in developing
nociceptive circuits. After validating the TNF-a antibody (Figures
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Figure 1. TNFR1 Is Expressed by Nociceptive Neurons, and TNF-a Is Expressed in Nociceptor Targets
(A–C) Quantification of TNFR1 colocalization the nociceptive markers TrkA (A), CGRP (B), and peripherin (C) in the P0 DRG. Scale bar represents 30 mm.
(D–G) Quantification of TNFR1 colocalization with the nociceptive markers TrkA (D), CGRP (E), and peripherin (F) plus IB4 (G) as a marker of nonpeptidergic
nociceptors in the P30 DRG. Scale bar represents 60 mm.
(H and I) TNF-a is enriched mainly in the epidermis at P0 (H) and P30 (I). Scale bar represents 120 mm.
(J) Expression of TNF-a in the marginal zone and dorsal horn neurons of the spinal cord. Scale bar represents 150 mm.
See also Figures S1 and S2.
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TNF-a/TNFR1 Signals Control Nociceptor DevelopmentS1E–S1G), we found that TNF-a is enriched on sensory neurons
in the P4DRG (Figure S1H), in the epidermis betweenP0 andP30
(Figures 1H and 1I), and in the marginal zone and second-
order spinal cord neurons at P7 (Figure 1J). Importantly, we found
that TNFR2, a close relative of TNFR1 that also binds TNF-a, was
absent from the DRG (Figure S1A) and spinal cord (Figure S1I).
Taken together these data suggest that sensory neurons, periph-
eral targets, and central targets express TNF-a, whichmay signal
to nociceptors exclusively through TNFR1 during critical periods
of nociceptor circuit development and maturation.
TNF-a-TNFR1 Signaling Suppresses Skin Innervation
and NGF-Dependent Neurite Growth Programs
During normal developmental processes, a critical function of
NGF-TrkA signaling is control of nociceptor neurite growth into
peripheral targets (Patel et al., 2000). If TNF-a-TNFR1 signaling
antagonizes NGF-TrkA-dependent growth of nociceptors into
peripheral targets, we would predict that axon overgrowth into
the skin would be observed in Tnfr1/ and Tnf/ mice. To
test whether TNF-a-TNFR1 signaling is indeed required, in vivo,for proper axon innervation of peripheral targets, we performed
immunohistochemical analyses for nociceptive fibers in the
epidermis, as described previously (Zylka et al., 2005). First,
we observed that there is an increased density of small-diameter
peripherin+ fibers in glabrous skin at P0 in Tnfr1/ and Tnf/
animals relative to wild-type (WT) (Figure 2A). We then stained
for the pan-axonal marker protein gene product 9.5 (PGP9.5)
and observed twice as many PGP9.5+ nociceptive fibers projec-
ting into the epidermis in Tnfr1/ or Tnf/ mice than WT mice
by P30, suggesting that TNF-a and TNFR1 normally suppress
neurite growth programs in the periphery (Figures 2B and 2C).
Finally, whole-mount substance P immunostaining of the fore-
paw revealed that as early as E14.5, nociceptive fibers densely
innervate the digits and footpad of the paw in mice lacking
TNF-a or TNFR1 (Figure 2D). Taken together these data suggest
that the TNF-a-TNFR1 pathway is critical in regulating growth
and refinement of nociceptor peripheral projections in vivo.
To examine the role of TNFR1onNGF-TrkA-dependent neurite
growth in vitro, we established dissociated sensory neurons from
WT, Tnfr1/, or Tnf/ mice in microfluidic devices, whichNeuron 82, 587–602, May 7, 2014 ª2014 Elsevier Inc. 589
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Figure 2. Tnfr1–/– and Tnf–/– Nociceptive
Fibers Hyperinnervate the Skin and Are
Hypersensitive to NGF-Dependent Growth
(A) Peripherin immunostaining of hindpaw thin
glabrous skin. Arrows point to axons sprouting into
the cutaneous field. Scale bar represents 50 mm.
Quantification shown is peripherin+ fiber cuta-
neous field density normalized as percent of WT
mean. Five animals of each genotype were
examined.
(B and C) PGP9.5 immunostaining of thin glabrous
skin and quantification of epidermal innervation.
(B) P30 thin glabrous skin. Arrows point to invading
fibers. (C) Quantification of the number of PGP9.5
neurites crossing into the epidermal field at P0 and
P30, normalized to percent of WT. Five animals of
each genotype were analyzed per time point.
Scale bar represents 25 mm.
(D) Representative whole-mount immunostaining
of E14.5 forepaws for the peptidergic nociceptor
marker substance P; n = 4 paws from four mice
stained per genotype. Scale bar represents 50 mm.
(E) In vitro neurite growth of E14.5 TrkA+ noci-
ceptors grown in NGF and measured in compart-
mentalized chambers. Data shown are from two to
six independent experiments for each condition.
(F–I) Tuj1 immunostaining in WT (F), Tnfr1/ (G),
and Tnf/ (H) and quantification (I) of E14.5
explant outgrowth in response to 45 ng/ml NGF for
24 hr. Scale bar represents 500 mm. Explants were
from three or more mice per genotype.
One-way (I) or two-way (C and E) ANOVA, Bon-
ferroni posttest. Data represent mean ± SEM. ns,
not significant; *p < 0.05; **p < 0.01; ***p < 0.001.
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2010). We found that WT neurons bathed in NGF along with
TNF-a or brain-derived neurotrophic factor (BDNF) showed
significantly lower rates of neurite growth than WT neurons
bathed in NGF alone (Figure 2E). Strikingly, Tnfr1/ neurites
grew roughly five times faster than WT neurons in response to
10 ng/ml NGF, suggesting that TNFR1 plays a role in suppressing
NGF-dependent neurite growth (Figure 2E). Although TNF-a had
no effect on NGF-dependent neurite growth in Tnfr1/ neurons,
we observed that BDNF still slowed neurite growth in Tnfr1/
neuronsbathed inNGF, albeit to a lesser degree thanBDNF treat-
ment on WT mice neurons (Figure 2E). Interestingly, neurite
growth of dissociated Tnf/ neurons revealed separable roles
for TNF-a and TNFR1, suggesting that TNFR1 may suppress
nociceptor neurite growth in the absence of TNF-a. To assess
the effect of NGF-mediated neurite growth on whole ganglia
from Tnfr1/ and Tnf/ mice, E14.5 DRG explants were
cultured in NGF, yielding results corroborating excessive NGF-
dependent growth in the Tnfr1/ and Tnf/ explants; Tnfr1/
and Tnf/ neurites grew approximately three times faster than
WT neurites (Figures 2F–2I). It is possible that paracrine, rather
than autocrine, axon pruning programs are more dominant,590 Neuron 82, 587–602, May 7, 2014 ª2014 Elsevier Inc.yielding the difference in relative neurite
growth rates between dissociated Tnf/
nociceptors and explant cultures. To-gether, these data suggest that neurons lacking Tnfr1 or Tnf are
more responsive to NGF in the context of in vitro neurite growth
assays due to loss of TNF-a-TNFR1 forward signaling.
TNF-a-TNFR1Signaling Is Required for ProperGuidance
of Peptidergic Central Projections
In Tnfr1/ and Tnf/ mice, nociceptor peripheral projections
display phenotypes reminiscent of those observed in classical
NGF-TrkA gain-of-function experiments, demonstrating fiber
overgrowth into peripheral targets (Aloe et al., 1975). Therefore,
we sought to test whether nociceptor central projections were
disrupted similar to peripheral projections in Tnfr1/ and Tnf/
mice. To address this, we compared peptidergic (TrkA+,
CGRP+) central projections in the spinal cord between WT,
Tnfr1/, and Tnf/ mice at P0, P7, and P30. We noted com-
plete segregation of peptidergic (CGRP+) and nonpeptidergic
(IB4+) axons in the dorsal horn by P30 (Figures S3A–S3C), sug-
gesting that nonpeptidergic nociceptor fate specification is
intact (Chen et al., 2006b). However, we found that mice lacking
Tnfr1 or Tnf display an50% larger area occupied by TrkA+ and
CGRP+ peptidergic fibers thanWT lumbar dorsal horn at P0 (Fig-
ures 3A–3G). Moreover, most sections contained axon bundles
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Figure 3. Tnfr1–/– and Tnf–/– Peptidergic Central Projections Are Robust and Misguided
(A–H) TrkA and CGRP immunostaining in P0 WT (A and B), Tnfr1/ (C and D), and Tnf/ (E and F) lumbar spinal cord. Quantification of area (G) and lateral
projections (H) within WT, Tnfr1/, and Tnf/ spinal cord sections. Scale bar represents 100 mm.
(I–X) Immunostaining and quantification of P7 (I–P) and P30 (Q–X) lumbar spinal cord.
See also Figure S3. Two-way ANOVA, Bonferroni posttest (G, O, and W) and Fisher’s exact test (H, P, and X). Five mice were analyzed per genotype per time
point. Data represent mean ± SEM. ns, not significant; *p < 0.05; **p < 0.01; ***p < 0.001.
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Figure 4. Deletion of Tnfr1 or Tnf Leads to the Premature Differentiation and Impaired Growth of Nonpeptidergic Nociceptors
(A) Quantification of the number of TrkA+ sensory neurons in the L4/L5 DRG at P0, P14, and P30.
(B–D) Representative images of Ret/TrkA colocalization in the P0 DRG fromWT (B), Tnfr1/ (C), and Tnf/ (D) mice. Scale bar represents 30 mm. Quantification
of colocalization is shown on overlay.
(E) Quantification of the number of IB4+ neurons in the L4/L5 DRG at P14 and P30.
(F–M) Immunostaining and quantification of IB4+ axons invading the spinal cord dorsal horn at P14 (F–H) and P30 (I–K) in WT, Tnfr1/, and Tnf/ mice.
Quantification of IB4+ axon area shown in (L) and (M). Scale bar represents 100 mm.
(legend continued on next page)
Neuron
TNF-a/TNFR1 Signals Control Nociceptor Development
592 Neuron 82, 587–602, May 7, 2014 ª2014 Elsevier Inc.
Neuron
TNF-a/TNFR1 Signals Control Nociceptor Developmentthat misprojected within the dorsal horn and extended
medially and/or laterally (Figure 3H). The same analyses
performed at P7 and P30 revealed similar phenotypes, sug-
gesting that central projection defects are stable even after
terminal differentiation (Figures 3I–3X). The enhanced growth
and misguidance of Tnfr1/ and Tnf/ central projections
are reminiscent of other pathways that negatively modulate
NGF-dependent central projections such as HoxD1 (Guo et al.,
2011), suggesting that TNF-a-TNFR1 signaling is also required
for proper growth and refinement of nociceptor central
projections.
TNF-a-TNFR1 Signaling Coordinates Nociceptor
Differentiation
There are several possible explanations for the increase in pep-
tidergic peripheral and central projection densities that occur in
Tnfr1/ and Tnf/ mice: (1) an increase in the neurite density
of individual nociceptors; and/or (2) more nociceptors in the
DRG, which would increase the overall number of fibers projec-
ting to the skin and spinal cord. Although we have established
that loss of TNFR1 signaling enhances NGF-dependent neurite
growth, it is also possible that TNFR1 antagonizes nonaxon
growth aspects of NGF-TrkA signaling such as cell death and
differentiation in the DRG. To test this possibility we examined
cell number in the DRG by counting the number of TrkA+ noci-
ceptors at P0, P14, and P30, time points corresponding to key
regulatory events in the survival and differentiation of nocicep-
tors (Marmige`re and Ernfors, 2007). Surprisingly, we observed
a significant decrease in the TrkA+ nociceptor population at
P0 in Tnfr1/ and Tnf/ mice but, relative to WT, more
TrkA+ neurons at P14 and P30 (Figure 4A). It is possible that
the appearance of fewer TrkA+ neurons at P0 may not be due
to an altered trophic threshold for survival; rather, it may have
to do with altered differentiation programs. Indeed, it is estab-
lished that early TrkA+ nociceptors downregulate TrkA/CGRP
and upregulate Ret to become nonpeptidergic nociceptors
through a process that is itself dependent on the strength of
NGF-TrkA signals (Luo et al., 2007). Thus, if a Tnf or Tnfr1 dele-
tion enhances NGF sensitivity in TrkA+ nociceptors, an
increased number of early TrkA+ neurons would be driven to-
ward a nonpeptidergic fate. To examine this possibility, we as-
sessed putative nonpeptidergic cell number in the DRG by
counting the number of Ret+/TrkA+ (differentiating) and IB4+
(terminally differentiated) neurons across time, as described
previously (Luo et al., 2007). The number of differentiating
Ret+/TrkA+ cells in Tnfr1/ or Tnf/ P0 DRGs was approxi-
mately three times higher than the number of differentiating
neurons in WT mice (Figures 4B–4D). At P14 and P30, the in-
crease in nonpeptidergic neuron number persists in Tnfr1/
and Tnf/ mice compared to WT (Figure 4E). These data sug-
gest that TNF-a-TNFR1 signals work during nociceptive differ-
entiation to dampen the NGF-TrkA-dependent drive toward a
nonpeptidergic fate and that loss of these signals leads(N–S) E14.5 DRG explants cultured in 100 ng/ml NRTN (N–P), 100 ng/ml NRTN + 2
from three or more mice per condition. Scale bar represents 100 mm.
One-way ANOVA, Bonferroni posttest (A, L, and M) or Tukey posttest (S). Two-wa
and (E). Five mice were analyzed in (L) and (M). Data represent mean ± SEM. nsto higher numbers of both peptidergic and nonpeptidergic
nociceptors.
TNFR1-TNF-a Signaling Is Required for Nonpeptidergic
Nociceptor Axon Extension into the Spinal Cord and
NRTN-Dependent Neurite Outgrowth
We next sought to determine whether TNF-a and TNFR1
specifically influence developmental processes in TrkA+ neu-
rons or can more broadly affect other nociceptor pools such as
Ret-expressing nonpeptidergic neurons. To address this we
used WT, Tnfr1/, and Tnf/ mice to evaluate whether the
extent of nonpeptidergic central projections would reflect the
robust expansion into the dorsal horn observed for peptidergic
nociceptor central projections. Surprisingly, there was approxi-
mately a 30%–50% reduction in the area devoted to nonpepti-
dergic, IB4+ axons in the dorsal horn at P14 and P30 in Tnfr1/
or Tnf/ mice relative to WT mice (Figures 4F–4M). Having
observed an increase in the number of these nonpeptidergic,
IB4+ cells in Tnfr1/ and Tnf/ mice, this finding suggests
that TNF-a-TNFR1 signaling is required for the maintenance of
nonpeptidergic nociceptor central projections.
A well-established signaling pathway implicated in promoting
the growth of nonpeptidergic nociceptive axons is through the
ligand, coreceptor, and RTK: NRTN, GFRa2, and Ret, respec-
tively (Stucky and Lewin, 1999; Airaksinen and Saarma, 2002;
Lindfors et al., 2006; Luo et al., 2007). Therefore, we next asked
whether loss of TNF-a or its receptor could influence Ret-depen-
dent neurite growth. To this end, we cultured E14.5 DRG ex-
plants from WT, Tnfr1/, and Tnf/ mice in 100 ng/ml NRTN.
Surprisingly, in response to NRTN, neurite outgrowth was signif-
icantly lower in Tnfr1/ and Tnf/ explants compared to WT
(Figures 4N–4P), consistent with in vivo observations of
decreased density of nonpeptidergic axons in lamina IIi of the
spinal cord.We initially attempted to rescue this impaired neurite
outgrowth by activating TNF-a-TNFR1 forward signaling through
incubation of Tnf/ explants in TNF-a+NRTN (Figure 4Q), which
yielded no significant differences compared to the growth of
Tnf/ explants grown solely in NRTN (Figure 4S). Given that a
recent study implicated TNFR1-TNF-a reverse signaling (Sun
and Fink, 2007) in the growth of sympathetic axons (Kisiswa
et al., 2013), we hypothesized that perhaps TNF-a-TNFR1
reverse signaling, rather than forward signaling, is responsible
for nonpeptidergic neurite outgrowth. We tested this idea by
incubating E14.5 explant cultures in NRTN as well as selective
readdition of soluble TNFR1 (sTNFR1) to Tnfr1/ explants to
activate TNFR1-TNF-a reverse signaling pathways. Consistent
with a reverse signaling paradigm, sTNFR1 addition to Tnfr1/
explants restored neurite growth to WT levels (Figures 4R and
4S). These data suggest that in contrast to the repressive effects
of TNF-a-TNFR1 forward signaling on NGF-TrkA-dependent
growth, a TNFR1-TNF-a reverse signaling program enhances
NRTN-GFRa2-Ret-dependent neurite growth in nonpeptidergic
nociceptors.ng/ml TNF (Q), or 100 ng/ml NRTN + 5 mg/ml sTNFR1 (R) for 24 hr. Explants are
y ANOVA, Bonferroni posttest (E). Number of mice analyzed is indicated in (A)
, not significant; *p < 0.05; **p < 0.01; ***p < 0.001.
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Figure 5. TNF-a-TNFR1 Signaling Differen-
tially Regulates the Excitability of Peptider-
gic and Nonpeptidergic Nociceptors
(A) Fluo-4 AM in vitro calcium imaging of E14.5
nociceptors. The changes in fluorescence of E14.5
TrkA+ nociceptors were measured (cultured in
45 ng/ml NGF for 3 days in vitro) after acute
addition of the indicated TRP channel agonist.
Two experiments per condition are reported; at
least three mice per experiment were used.
(B) Rescue experiment demonstrating that TNF-a
is sufficient to quench the hyperexcitability of
Tnf/ nociceptors. E14.5 nociceptors from WT or
Tnf/ mice were cultured in 1 ng/ml NGF (with or
without TNF for Tnf/ neurons) for 2 days in vitro
and prepared for calcium imaging as in (A). Two
experiments per condition are reported; at least
three mice per experiment were used.
(C) Representative image of P14 calcium imaging
strategy examining nonpeptidergic nociceptor
excitability. IB4+ and IB4 neurons are shown
before and after agonist addition. Red arrow, IB4
neuron; white arrow, IB4+ neuron. Scale bar rep-
resents 20 mm.
(D) Quantification of fluorescence changes of P14
nociceptors (cultured in 45 ng/ml NGF for 1 day
in vitro) in response to 1,000 mM ATP.
(E) Excitability of P14 IB4+ and IB4 nociceptors
responding to capsaicin. Two to three experi-
ments per condition are reported; three mice per
experiment were used.
See also Figure S4. Statistics determined by one-
way (A, B, D, and E) ANOVA, Bonferroni posttest.
Data represent mean ± SEM. *p < 0.05, **p < 0.01,
***p < 0.001.
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TNF-a/TNFR1 Signals Control Nociceptor DevelopmentTNF-a and TNFR1 Are Required to Differentially
Regulate the Excitability of Peptidergic and
Nonpeptidergic Nociceptors
Nociceptors sense thermal, mechanical, and chemical stimuli
through the expression of different ion channels such as the tran-
sient receptor potential (TRP) family of ion channels (Clapham,
2003; Moran et al., 2011). Importantly, RTK signaling modulates
the excitability of ion channels in nociceptors. For instance,
NGF-TrkA signaling can enhance the expression and sensitivity
of TRP ion channels in peptidergic nociceptors (Chuang et al.,
2001; Zhang et al., 2005; Ji et al., 2002; Luo et al., 2007), whereas
NRTN-GFRa2-Ret signaling regulates expression of the ATP-
gated ion channel P2X purinoceptor 3 in nonpeptidergic noci-
ceptors (Wang et al., 2013). To test whether Tnfr1/ and Tnf/
peptidergic nociceptors exhibit altered excitability, we per-
formed calcium imaging in cultured E14.5 TrkA+ sensory neu-
rons, similar to previous studies (Liu et al., 2009). Neurons
were stimulated with mustard oil, menthol, and capsaicin,
specific agonists of the temperature-sensitive TRP channels
TRPA1, TRPM8, and TRPV1, respectively (Caterina et al.,
1997; Peier et al., 2002; Bandell et al., 2004). Upon stimulation
with any of the three agonists, Tnfr1/ and Tnf/ TrkA+
neurons were hypersensitive to each of the chemical analogs
relative to WT neurons (Figure 5A). We also conducted a rescue
experiment to determine whether TNF-a is sufficient to quench
the hyperexcitability of Tnf/ nociceptors. We incubated594 Neuron 82, 587–602, May 7, 2014 ª2014 Elsevier Inc.E14.5 nociceptors from WT and Tnf/ mice in 1 ng/ml NGF
and observed hyperexcitability of Tnf/ nociceptors relative to
WT, analogous to the effects observed in 45 ng/ml NGF. How-
ever, when we selectively added 2 ng/ml TNF-a to Tnf/ noci-
ceptors cultured in 1 ng/ml NGF, we were able to restore TRP
channel activity to WT levels (Figure 5B). This suggests that
TNF-a-TNFR1 forward signaling negatively regulates the excit-
ability of TRP channels in TrkA+ nociceptors and most promi-
nently, TRPV1. In addition, the reported fluorescence fold
changes are somewhat less robust than those reported in the
literature due to a longer working distance in the z-plane during
live imaging sessions (Figures S4A–S4C). This did not influence
our ability to accurately assess relative excitability between ge-
notypes (Figure S4D).
We also tested whether the excitability of nonpeptidergic
nociceptors is altered in the absence of TNF-a or TNFR1
because NRTN is known to regulate sensitivity of P2X ion chan-
nels (Wang et al., 2013). We used a strategy that permits
recording fluorescence changes exclusively in nonpeptidergic
nociceptors by incubating the cultures with Alexa 568-conju-
gated IB4 before application of a chemical agonist (Figure 5C)
(Gerevich et al., 2004). In response to ATP stimulation, Tnfr1/
and Tnf/ P14 IB4+ nociceptors were less excitable than WT
IB4+ neurons (Figure 5D). Because nonpeptidergic nociceptors
also express TRPV1 (Chen et al., 2006b; Luo et al., 2007), we
tested whether a similar effect was observed after capsaicin
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Figure 6. Tnfr1–/– and Tnf–/– Mice Are Hyper-
sensitive to Thermal and Mechanical Stimuli
(A–E) Behavioral sensitivity of WT, Tnfr1/, and
Tnf/ mice in response to the tail flick (A), Har-
greaves radiant heat (B), acetone drop (C), hot
plate (D), and von Frey (E) tests measuring reflexive
(A and B) or centrally mediated (C and D) thermal
pain thresholds or mechanical acuity (E).
We used n = 6mice per data point (aged P26–P56);
if n > 6 mice, it is indicated. Two-way (A, D, and E)
or one-way (B and C) ANOVA, Bonferroni posttest.
All mice shown are on a B6;129s mixed back-
ground. WT mice are background matched, non-
littermate controls for Tnfr1/ and Tnf/ mice.
See also Figure S5. Data represent mean ± SEM.
ns, not significant; *p < 0.05; **p < 0.01; ***p <
0.001.
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TNF-a/TNFR1 Signals Control Nociceptor Developmentstimulation. Indeed, IB4+ neurons from Tnfr1/ or Tnf/ noci-
ceptors were hypoexcitable to capsaicin stimulation compared
to WT, whereas IB4 nociceptors were hyperexcitable (Fig-
ure 5E). As observed for axon growth, these data suggest
opposing regulatory roles for TNF-a and TNFR1 in attenuating
excitability of TrkA+ peptidergic nociceptors or enhancing TRP
channel activity of Ret+ nonpeptidergic nociceptors.
Tnf–/– and Tnfr1–/– Mice Are Hypersensitive to Thermal
and Mechanical Stimuli
NGF-TrkA signaling controls nociceptor target innervation, cell
survival, fate specification, excitability, and as a result, pain
sensitivity thresholds (Pezet and McMahon, 2006). Overactive
NGF signaling therefore causes hyperalgesia largely through
pathological hyperactivation of pathways regulating target inner-
vation and excitability (Smelter and Hochberg, 2013; Hefti et al.,
2006; Pezet andMcMahon, 2006). We found that excessive NGF
signaling and loss of TNFR1 or TNF-a signaling phenocopy one
another with respect to hyperinnervation of the skin and spinal
cord (Figures 2 and 3), hypersensitivity to TRP channel agonists
(Figure 5), aswell as a greater overall number of nociceptors (Fig-Neuron 82, 587ures 4A and 4E). Thus, we hypothesized
that developmental loss of TNF-a-
TNFR1 signaling would translate to
increased sensitivity to pain analogous
to injection with NGF (Lewin et al., 1993),
which can be assessed by behavioral
assays (for review, see Sandku¨hler,
2009). To test this hypothesis, we first
sought to precisely corroborate our cal-
cium imaging data by subjecting the
mice to a variety of different temperatures
at prescribed intervals. Toward this end,
we performed the tail flick assay where
tails of WT or mutant mice were sub-
merged in water ranging from 5C to
50C for no more than 20 s, and the
latency to tail withdrawal was measured.
Tnfr1/ and Tnf/ mice were signifi-
cantly more sensitive to every tempera-ture examined, including neutral temperatures between 25C
and 37C (Figure 6A). Hyperexcitability to all temperatures is
consistent with the sensitization of TRPV1, TRPM8, and
TRPA1 observed in our calcium imaging experiments (Figure 5A)
because Tnfr1/ and Tnf/mice were more responsive to hot,
cool, and freezing temperatures, respectively, in the behavioral
assays. Tnfr1/ and Tnf/ mice also responded more quickly
than WT in the Hargreaves radiant heat test, which applies
heat with no tactile cue (Figure 6B), further corroborating hyper-
sensitivity to heat in the absence of TNF-a or TNFR1. These
data are consistent with the notion that TNF-a-TNFR1 forward
signaling contributes to proper perception of temperature by
reducing nociceptor sensitivity thresholds.
In addition to measuring reflexive pain, we used two tests that
interrogate centrally mediated hot- and cold-sensing abilities:
the hot plate test and the acetone drop test. These tests quantify
grooming responses indicative of which temperatures mice
perceive as noxious. For the hot plate test we examined several
temperatures ranging frommild to noxious heat. Both ligand and
receptor null mice also displayed similar increases in grooming
behaviors in the acetone drop test, which simulates cold–602, May 7, 2014 ª2014 Elsevier Inc. 595
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TNF-a/TNFR1 Signals Control Nociceptor Developmentsensation (Figure 6C). Mice lacking Tnfr1 and Tnf had lower pain
thresholds for heat and consequently, an altered perception of
thermal stimuli compared to WT mice (Figure 6D). In addition
to enhanced reflexive acuity to pain, Tnfr1/ and Tnf/ mice
display skewed thresholds of which temperatures are noxious
and which are not, as they confuse the distinction between
mild and injurious temperatures in both tests.
To assay another form of tactile sensitivity, we testedmechan-
ical acuity in Tnfr1/ and Tnf/ mice. Reflexive mechanical
sensitivity can be probed with von Frey filaments of varying
diameter to determine the threshold sensitivity of a mechanical
force. In response to mild mechanical forces, both Tnfr1/
and Tnf/mice weremore acutely sensitive to von Frey filament
stimulation than WT (Figure 6F), suggesting that TNF-a-TNFR1
signaling can also shape and suppress perception ofmechanical
force in addition to reflexively and centrally mediated thermal
pain. These data were independently confirmed using littermate
controls 6–7 weeks of age (Figures S5A–S5E). Thus, we propose
that the TNF-a-TNFR1 forward signaling pathway functions to
tune primary nociceptors to properly interpret polymodal tactile
stimuli.
Deletion of Tnfr1 Rescues Pain Phenotypes Associated
with Ngf Heterozygosity
Our in vitro and in vivo data demonstrate a consistent role for
TNF-a-TNFR1 antagonism of NGF-TrkA function. Based on
these data we speculated that by modulating one pathway we
might be able to correct phenotypes observed in the other.
Although Ngf/ mice die perinatally (Crowley et al., 1994), it is
established that nociceptors in mice heterozygous for Ngf have
roughly 50% less cell survival and target innervation (Crowley
et al., 1994; Brennan et al., 1999). If the role of TNF-a-TNFR1
signaling is to antagonize NGF-TrkA signaling in nociceptors,
then we would predict that ablation of Tnfr1 would rescue pain
insensitivity phenotypes that might be associated with loss of
one Ngf allele. First, we performed an analysis of the number
of TrkA+ and IB4+ nociceptors in the P14 L4 or L5 DRG of
Tnfr1+/, Ngf+/, Tnfr1+/;Ngf+/, and Tnfr1/;Ngf+/ mice.
Consistent with the loss of 50% of target-derived NGF, Ngf+/
and Tnfr1+/;Ngf+/ mice exhibited roughly 50% fewer TrkA+
and IB4+ neurons at P14 compared to Tnfr1+/mice (Figure 7A).
Tnfr1/;Ngf+/ mice, by contrast, exhibited TrkA+ and IB4+
neuron numbers similar to Tnfr1+/, which suggests that loss
of Tnfr1 increases the NGF sensitivity of TrkA+ nociceptors,
thereby rescuing the impaired cell survival caused by Ngf
heterozygosity.
Next, we analyzed the central projections into the spinal cord
dorsal horn in Tnfr1+/, Ngf+/, Tnfr1+/;Ngf+/, and
Tnfr1/;Ngf+/ mice. As expected (Crowley et al., 1994), there
was roughly a 50% decrease in the area occupied by CGRP+
fibers in the dorsal horn at P14 in Ngf+/ and Tnfr1+/;Ngf+/
mice relative to Tnfr1+/ mice (Figures 7B–7F). Homozygous
Tnfr1 deletion can rescue this fiber deficiency in Tnfr1/;Ngf+/
mice, providing additional evidence for functional antagonism
between TNFR1 and TrkA in vivo. Although the number of non-
peptidergic nociceptors in the DRG is rescued by homozygous
elimination of Tnfr1, the area occupied by nonpeptidergic axons
in the dorsal horn was identical between Ngf+/, Tnfr1+/;Ngf+/,596 Neuron 82, 587–602, May 7, 2014 ª2014 Elsevier Inc.and Tnfr1/;Ngf+/ mice (Figures 7B and 7G–7J). This is con-
sistent with the idea that TNFR1 positively regulates the main-
tenance of IB4+ fibers and is also consistent with the notion
that TNFR1-TNF-a reverse signaling might be required for the
full elaboration of nonpeptidergic axons through cooperation
with NRTN signaling.
We next examined innervation of glabrous skin from the
hindpaw footpad of P14 Tnfr1+/, Ngf+/, Tnfr1+/;Ngf+/, and
Tnfr1/;Ngf+/mice by quantifying the number of CGRP+ fibers
projecting into the epidermis (Figures 7K–7O). This analysis
revealed a 50% reduction in epidermal innervation by CGRP+
fibers in Ngf+/ and Tnfr1+/;Ngf+/ mice compared to Tnfr1+/
mice. As predicted, the skin of Tnfr1/;Ngf+/ mice exhibited
peptidergic fiber innervation comparable to that of Tnfr1+/
mice, suggesting that TNFR1 opposes NGF-mediated growth
of peptidergic fibers in the periphery.
We performed behavioral analyses on Tnfr1+/, Ngf+/,
Tnfr1+/;Ngf+/, and Tnfr1/;Ngf+/ mice to determine whether
modulating nociceptor circuitry translated to changes in pain
perception. Ngf+/ and Tnfr1+/;Ngf+/ mice were less sensitive
than Tnfr1+/ mice when performing the hot plate task at 50C,
52.5C, and 55C (Figure 7P). As expected, the latency to onset
of rapid, sustained grooming was rescued in Tnfr1/;Ngf+/
mice when compared to the less sensitive Ngf+/ or Tnfr1+/;
Ngf+/ mice. These loss-of-function data indicate that ablation
of TNFR1 can sensitize TrkA signaling in nociceptors and thereby
compensate for reduced NGF availability.
In addition to our genetic approach, we sought to use a
biochemical approach to definitively test whether TNFR1 indeed
functions as a bona fide antagonist of NGF-TrkA signaling in
developing nociceptors. To test this, we cultured E14.5 sensory
neurons in NGF for 24 hr and assayed for the activation of
signaling molecules downstream of NGF-TrkA. We found that
Tnfr1/ sensory neurons exhibit increased activation of the
NGF-TrkA downstream effectors extracellular signal-regulated
kinase 1/2 (ERK1/2) after 24 hr in vitro relative to WT sensory
neurons (Figure 7Q). Moreover, we conducted an NGF depriva-
tion time course to measure whether Tnfr1/ sensory neurons
exhibit sustained activation of the NGF-TrkA pathway after the
removal of NGF. Indeed, Tnfr1/ neurons maintained hyper-
activation of phosphorylated (P)-ERK1/2, at intervals after NGF
withdrawal (Figure 7R) despite decaying at the same rate (Fig-
ure S6). These datamore directly demonstrate that TNFR1 atten-
uates the strength of NGF-TrkA trophic signals in developing
nociceptors.
DISCUSSION
This study describes dual roles for TNF-a and TNFR1 sig-
naling in the coordination of peptidergic and nonpeptidergic
nociceptive circuits during peripheral nervous system develop-
ment through forward and reverse signaling paradigms. We
demonstrate that, as early as E14.5 and as late as P30,
forward TNF-a-TNFR1 signals are required to negatively regu-
late the neurite growth, differentiation, and excitability of
peptidergic nociceptors. In contrast, TNFR1-TNF-a reverse
signaling is required for full target innervation by and excit-
ability of nonpeptidergic nociceptors between P14 and P30.
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Figure 7. Loss of Tnfr1 Can Compensate for Heterozygous Ngf Deletion
(A) Quantification of the number of TrkA+ and IB4+ neurons per L4/L5 DRG at P14. One DRG used per animal; the number of DRGs is indicated.
(B–J) Analysis of the P14 L4/L5 spinal cord dorsal horn innervation density of CGRP (C–F) and IB4 (G–J) fibers and quantification (B). Five animals were analyzed
per genotype; number of sections analyzed is indicated. Scale bar represents 50 mm.
(K–O) CGRP+ fiber density in P14 footpad (thick) glabrous skin. (L–O) Representative images of CGRP+ peptidergic nociceptor fibers invading the hindpaw
footpad of P14 mice. Arrowheads point to invading fibers. Scale bar represents 25 mm. (K) Quantification of peptidergic nociceptor skin innervation. Five mice
were analyzed per genotype.
(P) Hot plate behavioral analysis at 50C, 52.5C, and 55C. Behavioral analysis performed on mice from a mixed, B6;129 background. Mice analyzed are
littermate controls except Ngf+/, which are background matched.
(Q and R) Western blot (Q) and quantification (R) showing the decay in P-ERK1/2 signal after E14.5 nociceptors fromWT and Tnfr1/mice were deprived of NGF
via incubation with anti-NGF for the indicated times. Nociceptors were cultured in 45 ng/ml NGF for 1 day in vitro. Data are from three independent experiments
using cultured nociceptors from four to six mice per experiment per genotype. Two-way ANOVA, Holm-Sida´k posttest.
See also Figure S6. Statistics determined by one-way (K and P) or two-way (A and B) ANOVA, Tukey posttest. Data representmean ± SEM. ns, not significant; *p <
0.05; **p < 0.01; ***p < 0.001.
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TNF-a/TNFR1 Signals Control Nociceptor DevelopmentWe propose that these differential functions are principally
dependent on the complement of RTK signaling and trophic
factor responsiveness resident in different nociceptor popula-tions, specifically NGF-TrkA and NRTN-GFRa2-Ret in pepti-
dergic and nonpeptidergic nociceptors, respectively (Figures
8A and 8B).Neuron 82, 587–602, May 7, 2014 ª2014 Elsevier Inc. 597
A B Figure 8. Model of TNF-a-TNFR1 Signaling
Properties in NGF-Responsive and NRTN-
Responsive Peptidergic and Nonpeptider-
gic Nociceptors
(A) Model of TNFR1 and TrkA signaling events in
WT animals. TNF-a-TNFR1 forward signals sup-
press NGF-TrkA-dependent excitability, neurite
growth, survival, and differentiation. These signals
lead to proper specialization of some TrkA+
peptidergic nociceptors as Ret+ nonpeptidergic
neurons, which are approximately equal in number
to peptidergic cells in young adulthood (P30).
Nonpeptidergic nociceptors are dependent on
TNFR1-TNF-a reverse signaling for maximal neu-
rite outgrowth and excitability.
(B) Loss of TNF-aor TNFR1signaling causes a gain
of function of NGF-TrkA signals, hyperactivating
TrkA excitability, neurite growth, cell survival, and
differentiation pathways (thick arrows). Conse-
quently,more TrkA+neurons are driven to toward a
nonpeptidergic fate earlier during development,
which results in roughly 50%more IB4+neuronsby
youngadulthood (P30). In contrast, nonpeptidergic
nociceptors are deficient in excitability and NRTN-
dependent neurite growth in the absence of TNF-a
or TNFR1 (dashed arrows), possibly through loss of
a reverse signaling mechanism.
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TNF-a/TNFR1 Signals Control Nociceptor DevelopmentTNF-a-TNFR1 Forward Signaling Attenuates NGF-TrkA-
Dependent Constructive Processes in Peptidergic
Nociceptors
Our in vivo and in vitro results provide evidence that TNF-a and
TNFR1 are required for proper development of nociceptive
circuits through antagonism of NGF-TrkA signaling. Several lines
of evidence support this assertion, including the following: (1)
In vivo, Tnfr1/ and Tnf/ mice exhibit an increased density
of nociceptive fibers both peripherally and centrally (Figures
2A–2D and 3). (2) In vitro, Tnfr1/ and Tnf/ neurons are
more sensitive to NGF-mediated neurite growth (Figures 2E–
2I). (3) In vitro calcium imaging suggests that TNF-a-TNFR1
signaling normally suppresses the sensitivity of several TRP
channels in TrkA+ peptidergic nociceptors because TrkA+ noci-
ceptors are hyperexcitable in the absence of TNF-a-TNFR1
signaling (Figure 5A) but can be rescued via reactivation of this
pathway (Figure 5B). (4) We show that homozygous deletion of
Tnfr1 is sufficient to compensate for neurite growth and be-
havioral pain deficits caused by the loss of a single Ngf allele
(Figure 7). (5) Finally, we provide biochemical evidence of
TNFR-RTK antagonism in neurons, by showing that TNFR1 sup-
presses NGF-TrkA activation (Figures 7Q and 7R).
Our findings that TNF-a-TNFR1 signaling and NGF-TrkA
signaling mutually oppose one another in nociceptors are analo-
gous to the broad antagonistic function of p75NTR in sympa-
thetic neurons (Kaplan and Miller, 2000; Deppmann et al.,
2008). For instance, p75NTR prevents axon overgrowth (Yeo
et al., 1997; Singh et al., 2008), modulates electrical properties
(Luther and Birren, 2009), and expedites developmental cell
death (Deppmann et al., 2008) in sympathetic neurons. Although
p75NTR does not appear to play this role in sensory neurons (Lee
et al., 1992), we suggest that TNF-a and TNFR1 may have
assumed the antagonistic role toward NGF-TrkA processes in598 Neuron 82, 587–602, May 7, 2014 ª2014 Elsevier Inc.developing nociceptors. Indeed, loss of Tnfr1 leads to hyper-
activation of trophic pathways such as P-ERK1/2, consistent
with an increase in nonpeptidergic nociceptor number and pep-
tidergic nociceptor target innervation, as suggested previously
(Zhong et al., 2007; Newbern et al., 2011). This apparently direct
TNF-a-TNFR1 suppression of downstream neurotrophic signals
is reminiscent of a similar relationship with the insulin receptor
(Steinberg et al., 2006). Thus, it is interesting to speculate that
crosstalk between RTK and TNFR family members is a general
theme in neuroscience and cell biology. More specifically,
whether other TNFR family members also serve as prorefine-
ment mechanisms in sensory neurons is an interesting future
line of inquiry. DR6 is one likely candidate given its robust enrich-
ment in the DRG (Figure S1A) and its pronounced role in sensory
neuron degeneration (Nikolaev et al., 2009). One additional
avenue of future investigation will be to ask whether TNFR family
members can cooperate to facilitate prorefinement functions in
the somatosensory system.
TNF-a and TNFR1 Enhance Nonpeptidergic Nociceptor
Growth and Excitability
Despite increases in the number of IB4+ neurons in mice lacking
TNF-a or TNFR1, it appears that rather than Ret antagonism,
TNFR1 signaling cooperates with Ret in nonpeptidergic noci-
ceptors. Several lines of evidence support this synergistic rela-
tionship, including the following. (1) In vivo, a reduction in IB4+
fibers occupying lamina IIi at P14 and P30, despite the presence
of more nonpeptidergic neurons in the DRG at P14 and P30 (Fig-
ures 4F–4M). (2) In vitro, DRG explants from Tnfr1/ or Tnf/
mice display impaired neurite outgrowth in response to NRTN
(Figures 4N–4P and 4S). (3) Addition of sTNFR1, but not soluble
tumor necrosis factor (sTNF), rescues the impaired neurite
outgrowth of explants cultured in NRTN (Figures 4Q–4S). (4)
Neuron
TNF-a/TNFR1 Signals Control Nociceptor DevelopmentIn vitro calcium imaging assays reveal that Tnf/ and Tnfr1/
nonpeptidergic nociceptors are hypoexcitable to acute ATP
and capsaicin stimulation (Figures 5D and 5E). (5) The inability
of a Tnfr1 deletion to rescue deficient nonpeptidergic central
projections to lamina IIi caused by Ngf heterozygosity (Figures
7B and 7G–7J). These results point to a dichotomous function
for TNF-a and TNFR1 signals in two populations of functionally
distinct neurons and suggest that TNF-a and TNFR1 may
enhance growth and excitability through reverse signaling.
What is the molecular basis for predominantly TNF-a-TNFR1
forward signaling in peptidergic nociceptors but TNFR1-TNF-a
reverse signaling in nonpeptidergic nociceptors? One possibility
is that contextual molecular differences bias production of
sTNF-a or sTNFR1. For instance, just as NGF-TrkA signals upre-
gulate the expression of a disintegrin and metalloprotease 17
(ADAM17) in sympathetic neurons (Kommaddi et al., 2011), it is
possible that a similar paradigm exists in TrkA+ sensory neurons.
One could envision that strongly trophic TrkA+ nociceptors upre-
gulate ADAM17, which would cleave membrane-bound TNF-a
to produce sTNF-a and induce TNF-a-TNFR1 forward signals
in peptidergic nociceptors. Upon committing to a nonpeptider-
gic fate however, ADAM17 or other metalloproteasesmight pref-
erentially shed TNFR1 from the cell surface to generate sTNFR1.
Although further studies on these possibilities are necessary, it is
a compelling idea to consider the number of permutations of
TNFR family members antagonizing or synergizing with different
RTKs to promote vastly different functional outcomes such as
what we observe in peptidergic (TrkA+) and nonpeptidergic
(Ret+) nociceptors. As such, our findings likely extend beyond
neuronal populations specifically, and to RTK and TNFR family
member function, generally.
Cell Fate Specification of TrkA+ Sensory Neurons Is
Coordinated by TNF-a-TNFR1 Signaling
All newly born nociceptors are TrkA+ but mature to become
several diverse subpopulations expressing various combina-
tions of the RTKs TrkA, Ret, and Met during adulthood (Lalle-
mend and Ernfors, 2012; Liu and Ma, 2011; Gascon et al.,
2010; Luo et al., 2007). These fate specification events are re-
ported to be dependent on hierarchal NGF-TrkA modulation of
the RTK, Ret, and the transcription factor Runx1 (Lallemend
and Ernfors, 2012; Gascon et al., 2010; Luo et al., 2007; Chen
et al., 2006b). Thus, it stands to reason that perturbing TrkA
signals in developing sensory neurons would perturb the fate
specification of several different nociceptor lineages. How then
is such remarkable diversity coordinated from the standpoint
of an early TrkA-expressing nociceptor? We propose that
TNFR1 plays a pivotal role in the specification of different noci-
ceptor subtypes based on the following observations: (1) Elimi-
nation of TNF-a-TNFR1 signaling leads to higher numbers of
TrkA+ nociceptors in adulthood, consistent with previous reports
that TNF-a serves a death-promoting developmental role in
sensory neurons (Figure 4A) (Barker et al., 2001). (2) Loss of
TNFR1 or TNF-a also results in a higher proportion of nocicep-
tors moving toward a nonpeptidergic fate commitment at P0
(Figures 4B–4D). (3) Consistent with this idea, at P14 and P30
there are more IB4+ neurons in Tnfr1 and Tnf knockout animals
than WT mice in the L4/L5 DRG (Figure 4E).Previous work has demonstrated that loss of key transcription
factors impairs differentiation and function of sensory neurons
(Chen et al., 2006a, 2006b; Maricich et al., 2009; Wende et al.,
2012). Although the importance of TrkA and Met in regulating
nociceptor differentiation has already been established (Luo
et al., 2007; Gascon et al., 2010), to our knowledge TNFR1 is
the only non-RTK single-pass transmembrane protein reported
to influence sensory neuron fate specification. We find that
loss of TNF-a-TNFR1 signaling is more akin to enhancement of
TrkA-dependent differentiation as more nonpeptidergic noci-
ceptors are generated in the absence of TNF-a or TNFR1. These
observations are consistent with our biochemical data that
reveal loss of TNFR1 leads to hyperactive P-ERK1/2 signaling
(Figures 7Q and 7R) and previous reports implicating ERK/
mitogen-activated protein kinase signals in fate specification
(Zhong et al., 2007). Importantly, although we specifically focus
on the development of nonpeptidergic nociceptors derived
from TrkA+ precursors, there are several other distinct popula-
tions of cells derived from TrkA+ precursors that are likely
affected by loss of TNF-a or TNFR1 such as those expressing
mrg family members regulating pain, itch, or even low threshold
mechanosensation (Dong et al., 2001; Liu et al., 2009; Li et al.,
2011; Vrontou et al., 2013; Abraira and Ginty, 2013). In future
studies it will be interesting to examine how TNF-a and TNFR1
influence the development and specification of several important
sensory neuron subtypes critical for varied modes of tactile
perception.
TNF-a-TNFR1 Forward Signaling Gates NGF-TrkA
Signaling to Suppress Pain
Our data suggest that TNFR1 acts as a gatekeeper on noci-
ceptive neurons where it exerts control over several processes
underlying stimulus perception. Importantly, these data also
imply that TNF-a-TNFR1 signaling within nociceptors is, in
turn, controlled by the levels of TNF-a produced by tissues
that nociceptors innervate such as the skin and spinal cord.
TNF-a-TNFR1 signals modify nociceptor information processing
by attenuating NGF-TrkA signals and refining components of the
primary nociceptive circuit such that nociceptors properly inter-
pret painful touch. This study and findings from other groups
have demonstrated that elimination of NGF or TrkA signaling
results in nociceptive impairment (Crowley et al., 1994; Silos-
Santiago et al., 1995; Indo et al., 1996). Conversely, excessive
NGF-TrkA activation causes nociceptor sensitization (Pezet
and McMahon, 2006; Lane et al., 2010). Thus, deletion of Tnf
or Tnfr1 is analogous to increasing the sensitivity of nociceptors
to NGF stimulation, effectively increasing the ‘‘gain in pain’’
signals that are transmitted to the CNS (Figure 6), as suggested
previously (Woolf and Salter, 2000). In support of this notion, we
find that loss of TNFR1 can rescue the defective nociceptive
perception observed in mice heterozygous for Ngf. This rescue
can be observed for cell number, central projection, and periph-
eral innervation density as well as behavior (Figure 7). Impor-
tantly, we present biochemical evidence that suggests these
phenotypes are due to hyperactive NGF-TrkA signals in
nociceptors.
This study supports the emergent concept that development
of the peripheral nervous system requires a balance ofNeuron 82, 587–602, May 7, 2014 ª2014 Elsevier Inc. 599
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equation becomes unbalanced, we observe disorders such as
congenital insensitivity to pain or TNFR-associated periodic syn-
drome, an autoinflammatory disease marked by recurrent pain
and fever (Ozen and Bilginer, 2014). Although the idea that
TNFR family members negatively regulate the Trk family of
RTKs is not a new idea, the argument that the infamously proin-
flammatory TNF-a-TNFR1 pathway opposes pain perception is
significant. In fact, we report that nearly every major hallmark
of the NGF-TrkA pathway is augmented when Tnfr1 or Tnf is ab-
lated, suggesting a broad, general, and robust antagonism of
TrkA signaling in nociceptors. Surprisingly, although TNF-a and
TNFR1 are analgesic signals in TrkA+ nociceptors, they serve
an algesic role in Ret+ nociceptors, highlighting the importance
of molecular context in the formation of developing neural
circuits.EXPERIMENTAL PROCEDURES
Animals
All experiments were carried out in compliance with the Association for
Assessment of Laboratory Animal Care policies and approved by the Univer-
sity of Virginia Animal Care and Use Committee.
WT mice are on a B6;129 mixed background. Tnfr1a/ and Tnf/ mice
were purchased from The Jackson Laboratory and backcrossed to a B6;129
mixed background for four or more generations. Ngf+/ mice were a gift
from David Ginty and were maintained on a B6;129s mixed background.In Vitro Calcium Imaging
Calcium imaging was performed with Fluo-4 AM (Life Technologies) as
described previously (Suo et al., 2014), with some modifications. Briefly,
mass cultures of nociceptors were established in NGF, loaded with Fluo-4
AM, and then imaged before acute treatment with 1 mM capsaicin (MP Bio-
medicals), 100 mM L-menthol (MP Biomedicals), or 100 mM mustard oil (Acros
Organics). The change in fluorescence after treatment with a compound was
measured relative to baseline fluorescence, and a relative fold change was
computed. One chemical treatment was used per experiment. P14 cultures
were also loaded with IB4-568 (Life Technologies).Behavioral Assays
Mice were tested between 4 and 8 weeks (Figure 6), between 4 and 6 weeks
(Figure 7P), or between 6 and 7 weeks (Figure S5) during the light cycle. Before
testing, mice were habituated to handling. Behavioral experiments in Figure 6
were performed on mixed background matched (B6;129s), nonlittermate
controls. In Figure 7 behavioral experiments, Ngf+/ rescue experiments
were performed with littermate controls except for Ngf+/ mice, which were
background matched on the B6;129 mixed background.
Behavioral tests were performed with at least 20 min between tests, and no
more than three tests per day. One trial per mouse is reported for each data
point.
Tail Flick
Mice were manually restrained while the posterior 1/3 of the mouse’s tail was
submerged in a water bath (Fisher Scientific Isotemp) maintained at the desig-
nated temperature ±0.3C until mouse flicked or reacted to the temperature.
Hot Plate
Mice were placed on plates maintained at the given temperature (Columbus
Instruments Hotplate analgesia meter) and restricted to move within the area
of an inverted 1,000 ml beaker. The latency to vigorously lick/groom was
recorded.
Hargreaves
Amousewasmanually restrained, and its hindpawwas placed over an infrared
light source (Ugo Basile) until reflexive removal of paw.600 Neuron 82, 587–602, May 7, 2014 ª2014 Elsevier Inc.von Frey
Mice were placed on a thin mesh screen and restrained within slightly opaque
red containers during the test duration. Mechanical filaments of varying diam-
eter (Bioseb Touch Test) were administered to hindpaws beneath the appa-
ratus, and the percent response of paw lifting per five trials per filament was
recorded.
Acetone Drop
We applied 50 ml of acetone to the hindpaw and permitted it to evaporate for
10 s. The duration of grooming per 120 s after the evaporation was recorded.
Grooming was judged as forepaw/hindpaw/stomach licking, facial grooming,
and hindpaw dragging.
Quantitation of Images
Quantification of skin innervation was performed as described previously
(Zylka et al., 2005). DRG analyses were performed largely as described previ-
ously (Luo et al., 2007). Spinal cord quantification analyses were performed as
described previously (Guo et al., 2011).
RT-PCR, Immunostaining, Cell Culture, Explants, Dissociated
Neuron Neurite Growth, and Western Blotting
Detailed protocols are in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.neuron.2014.04.009.
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